KRAS and lung cancer: Lung cancers showed typical non-small cell lung cancer (NSCLC) driver alterations (KRAS G12D, RET fusions, PIK3CA mutations) and pervasive tumor suppressor loss, with no microsatellite instability (MSI)-high cases.